The BioCentury Show
The BioCentury Show
BioCentury
Ep. 91 – Annalisa Jenkins: How MHRA’s Reset Could Revive U.K. Biotech
36 minutes Posted Aug 22, 2025 at 3:00 am.
Introduction
State of U.K. Biotech
Improving U.K.’s Path to Clinic
What’s Next for MHRA
Changes at FDA
Working with China
0:00
36:07
Download MP3
Show notes
A new head at MHRA, a streamlined government life sciences strategy, and a more sophisticated innovation ecosystem have Annalisa Jenkins optimistic about the future of U.K. biotech — and its potential to carve out a stronger global role. On The BioCentury Show, Annalisa Jenkins, chair of Gemma Biotherapeutics, discussed the evolving landscape of biotech in the U.K. and the critical hurdles it faces as it implements the latest strategy. Jenkins, who was president and CEO of Dimension Therapeut...